AEYE Health Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $1.32M

  • Investors
  • 11

AEYE Health General Information

Description

Developer of an autonomous diagnostic screening technology designed for retinal imaging and point-of-care detection of diabetic retinopathy. The company utilizes artificial intelligence to deliver fully automated diagnostic screening, offering practical, accurate, and accessible retinal assessments at the point of care, enabling healthcare providers to efficiently identify and manage diabetic retinopathy and improve patient outcomes through early detection and streamlined workflows

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1501 Broadway
  • 12th Floor
  • New York, NY 10036
  • United States
+1 (866)
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Other Healthcare Technology Systems
Corporate Office
  • 1501 Broadway
  • 12th Floor
  • New York, NY 10036
  • United States
+1 (866)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AEYE Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Equity Crowdfunding 08-Nov-2023 $1.32M Completed Generating Revenue
9. Later Stage VC (Series C) 01-Apr-2022 Completed Generating Revenue
8. Early Stage VC (Series B) 21-Mar-2021 Completed Generating Revenue
7. Grant 01-Jul-2020 Completed Generating Revenue
6. Seed Round 01-Feb-2020 Completed Generating Revenue
5. Accelerator/Incubator 15-Jan-2020 Completed Generating Revenue
4. Seed Round Completed Startup
3. Accelerator/Incubator Completed Startup
2. Angel (individual) Completed Startup
1. Angel (individual) 01-Nov-2018 Completed Startup
To view AEYE Health’s complete valuation and funding history, request access »

AEYE Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-3
Series B-2
Series B-1 754,511 $0.001000 $2.83 $2.83 1x $2.83 10.04%
Series A 1,170,869 $0.001000 $0.98 $0.98 1x $0.98 15.58%
To view AEYE Health’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AEYE Health Patents

AEYE Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12493958-B2 Method and system for predicting manifestation or progression of a retinal malady and method for training machine learning (ml) models for the same Active 02-Mar-2022
US-20230281816-A1 Method and system for predicting manifestation or progression of a retinal malady and method for training machine learning (ml) models for the same Active 02-Mar-2022
WO-2022149082-A1 Retinal imaging quality assessment and filtering method using blood vessel characteristics and visibility Inactive 06-Jan-2021
US-20200273164-A1 Blood vessels analysis methodology for the detection of retina abnormalities Inactive 19-Oct-2017
WO-2019077613-A1 Blood vessels analysis methodology for the detection of retina abnormalities Inactive 19-Oct-2017 G06T7/0012
To view AEYE Health’s complete patent history, request access »

AEYE Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AEYE Health Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ambit Health Ventures Venture Capital Minority
OurCrowd Venture Capital Minority
BioLight Life Sciences Venture Capital Minority
SK Group Israel Corporation Minority
Angel (individual) Minority
You’re viewing 5 of 11 investors. Get the full list »

AEYE Health FAQs

  • When was AEYE Health founded?

    AEYE Health was founded in 2018.

  • Where is AEYE Health headquartered?

    AEYE Health is headquartered in New York, NY.

  • What is the size of AEYE Health?

    AEYE Health has 37 total employees.

  • What industry is AEYE Health in?

    AEYE Health’s primary industry is Diagnostic Equipment.

  • Is AEYE Health a private or public company?

    AEYE Health is a Private company.

  • What is AEYE Health’s current revenue?

    The current revenue for AEYE Health is .

  • How much funding has AEYE Health raised over time?

    AEYE Health has raised $28.3M.

  • Who are AEYE Health’s investors?

    Ambit Health Ventures, OurCrowd, BioLight Life Sciences, SK Group Israel, and are 5 of 11 investors who have invested in AEYE Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process